WARRANT AGREEMENTWarrant Agreement • July 18th, 2018 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
THIS WARRANT AGREEMENT made as of July 16, 2018 (the “Issuance Date”), between SELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”), Computershare Inc., a Delaware corporation (“Computershare”), and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company (and together with Computershare, the “Warrant Agent”).
SELLAS Life Sciences Group, Inc. 6,845,000 Shares Common Stock ($0.0001 par value per share) and Pre-Funded Warrants to Purchase up to 4,675,000 Shares of Common Stock and Warrants to Purchase up to 11,520,000 Shares of Common Stock Underwriting AgreementSELLAS Life Sciences Group, Inc. • July 18th, 2018 • Pharmaceutical preparations • New York
SELLAS Life Sciences Group, Inc., a corporation organized under the laws of Delaware (including any predecessor entities, the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, (i) an aggregate of 6,845,000 shares of common stock, $0.0001 par value per share (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Shares”), (ii) pre-funded warrants to purchase up to an aggregate of 4,675,000 shares of Common Stock (the “Pre-Funded Warrants”) at an exercise price of $0.0001 per share and (iii) warrants of the Company to purchase up to an aggregate of
